Heart disease is the No. 1 cause of death for men and women in the US and the world.
There are multiple disorders associated with the loss of cardiac function and destruction of cardiac tissue. However, most therapies treating heart disease are primarily palliative, according to the National Institutes of Health.
Stem cell therapy can address the problem of heart disease – and stretches its treatment beyond palliative care with a profound effect.
Heart transplants have been the primary approach to treating cardiac tissue loss, but stem cell therapy is becoming a more promising and less invasive approach by transplanting healthy cells in order to renew and repair damaged heart tissue.
When the heart has undergone significant damage, scar tissue becomes an issue as does the irreversible loss of cardiomyocytes, muscle cells that contribute to the force and rhythmic beating of the heart. Stem cell therapy, when used to treat cardiac disease and repair the heart, may also restore those critical cardiomyocyte cells.
Stem cell therapy for treating cardiovascular disease involves using a catheter to deliver the stem cells to the heart. Studies and clinical trials are promising. The cells have successfully transformed into healthy heart and blood cells. Stem cells have been taken from the following sources: patient’s own heart or bone marrow, and donated umbilical cord blood.
The Bottom Line
Just as stem cells can be delivered to damaged areas of the body, successfully triggering healing, so too can they be delivered to the heart muscle to help heal damaged tissue as the result of heart disease.
However, before seeking stem cell treatment for heart disease, it is crucial to locate a reputable clinic that is approved by the FDA. Unregulated clinics are causing more harm than good. Systemic Laboratories operates under a professional and ethical code of conduct and the lab adheres to and complies with all regulatory guidelines. For more information, call (718) 268-6060.